Fluoroquinolones vs amoxicillin
Serious adverse events · adults aged 18 years and above with diagnosis of non‐cystic fibrosis bronchiectasis
1 finding from 1 review
- no estimate extracted2 studies · 83 participantsLow
Findings
What do systematic reviews say?
6 questions · 6 findings · 2 reviews
No studies found 1 · 16.7%GRADE not reported 0 · 0%Very low 4 · 66.7%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%
Fluoroquinolones vs macrolides
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Fluoroquinolones vs beta‐lactams
Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 1.03 [0.77, 1.39]4 studies · 570 participantsVery low
Fluoroquinolones vs macrolides
Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with macrolides (very low certainty).
1 finding from 1 review
- RR 1.33 [0.32, 5.56]1 study · 76 participantsVery low
Fluoroquinolones vs beta‐lactams
Serious adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes serious adverse events clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 10.9 [0.61, 194.82]1 study · 221 participantsVery low
Fluoroquinolones vs beta‐lactams
Discontinuation of medication due to adverse events · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes adverse events leading to discontinuation of treatment compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 1.02 [0.27, 3.89]1 study · 127 participantsVery low